Two of the most covered stocks this year are Palantir and UnitedHealth Group, but the reasons why couldn't be further apart.

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth Group shares appear undervalued after 50% decline, and concerns about a potential DOJ investigation seem ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

We recently published a list of Jim Cramer Says Trump’s One Big, Beautiful Bill Is Pro Growth & Discusses These 12 Stocks. In ...

UnitedHealth Group Chairman Stephen Hemsley is returning to helm the health care conglomerate once again. He will replace Andrew Witty effective immediately.

Simultaneously, AM Best has revised the outlook to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) for the health and ...

Furthermore, UnitedHealth Group had a large amount of goodwill and intangibles on the balance sheet totaling approximately 132% of equity. There has been no history of any material impairments and ...

UnitedHealth Group (NYSE:UNH) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high.

Hemsley has a longstanding history with the company, joining UnitedHealth Group as chief operating officer in 1997 and becoming president two years later. He became board chair in 2017.